Article 14 Jan 2021 GSK v. Teva: The Skinny On Induced Infringement And Label Carve-Outs United States IP
Article 06 Jan 2021 Industry Insights By Jeremy Levin, Chair And CEO Of Ovid Therapeutics And Board Chair Of BIO (AdvanSE Life Sciences Conference 2020) United States Healthcare
Article 22 Jan 2015 PTAB Denies Request To Use Covered Business Method Review For Orange Book-Listed Patents United States IP